3062, 3030, 2932, 1454, 1363, 1203, 1162, 1096, 739, 698 cm−1; 1H
NMR (400 MHz, CDCl3) d 3.54 (3H, s), 3.75 (1H, dd, J = 10.1,
3.2 Hz), 4.50 (1H, dd, J = 10.1, 6.9 Hz), 4.73–4.80 (4H, m), 4.87
(1H, d, J = 11.0 Hz), 4.91 (1H, d, J = 12.1 Hz), 5.12 (1H, d, J =
11.0 Hz), 5.56 (1H, d, J = 3.2 Hz), 7.29–7.42 (15H, m), 7.52 (1H,
s). 13C NMR (100 MHz, CDCl3) d 58.1, 72.8, 73.5, 73.7, 75.5, 78.1,
79.4, 84.7, 127.9, 128.1, 128.1, 128.2, 128.2, 128.4, 128.5, 128.6,
128.7, 132.6, 133.4, 137.2, 137.2, 138.1; MS (ESI-TOF) m/z 472
[M + H]+; HRMS calcd for C28H30N3O4 [M + H]+, 472.2236;
found, 472.2214. 5a-b was the less polar isomer. Colorless oil. [a]D25
(c 0.50, CHCl3) −34.6; IR (neat) m 3062, 3031, 1454, 1359, 1224,
was added at 0 ◦C. After being stirred at room temperature for
3 h, the reaction mixture was quenched with H2O (25 mL) and
extracted with hexane (25 mL × 3). The combined organic layer
was dried over MgSO4 and evaporated. The residue was purified
by column chromatography on silica gel (hexane–EtOAc = 50 :
1) to give the TBS ether 7a in 94% yield (2.76 g, 4.70 mmol).
Colorless oil. [a]2D5 (c 1.01, CHCl3) −7.96; IR (neat) m 3031, 2928,
2856, 1455, 1254, 1092, 1028, 837, 733, 697 cm−1; 1H NMR
(400 MHz, CDCl3) d 0.00 (6H, s), 0.88 (9H, s), 3.61–3.75 (4H, m),
4.16 (1H, t, J = 6.6 Hz), 4.41 (1H, d, J = 11.5 Hz), 4.56 (1H, d,
J = 11.7 Hz), 4.63 (1H, d, J = 11.7 Hz), 4.71 (2H, d, J = 11.8
Hz), 4.83 (1H, d, J = 11.5 Hz), 5.25 (1H, brd, J = 14.7 Hz), 5.28
(1H, brd, J = 8.0 Hz), 5.77–5.89 (1H, m), 7.23–7.38 (15H, m);
13C NMR (100 MHz, CDCl3) d −5.5, 18.1, 25.9, 62.7, 70.7, 73.0,
75.1, 80.0, 81.1, 81.5, 118.6, 127.4, 127.4, 127.8, 128.0, 128.1,
128.2, 128.2, 128.4, 135.7, 138.5, 138.8, 138.9; MS (ESI-TOF)
m/z 555 [M + Na]+; HRMS calcd for C33H44NaO4Si [M + Na]+,
555.2907; found, 555.2884.
1
1156, 1090, 739, 698 cm−1; H NMR (400 MHz, CDCl3) d 3.61
(3H, s), 3.83 (1H, dd, J = 7.4, 6.2 Hz), 4.02 (1H, dd, J = 6.2,
4.0 Hz), 4.69 (1H, d, J = 11.5 Hz), 4.73 (1H, d, J = 11.5 Hz), 4.75
(1H, d, J = 11.4 Hz), 4.79 (1H, d, J = 11.4 Hz), 4.81 (1H, d, J =
7.4 Hz), 4.83 (1H, d, J = 11.6 Hz), 4.88 (1H, d, J = 11.6 Hz), 5.60
(1H, d, J = 4.0 Hz), 7.29–7.38 (15H, m), 7.60 (1H, s); 13C NMR
(100 MHz, CDCl3) d 58.5, 73.8, 73.8, 74.0, 74.4, 80.9, 82.5, 88.9,
127.9, 128.0, 128.0, 128.1, 128.1, 128.5, 128.6, 128.6, 130.8, 134.5,
137.1, 137.3, 137.6; MS (ESI-TOF) m/z 472 [M + H]+; HRMS
calcd for C28H30N3O4 [M + H]+, 472.2236; found, 472.2213.
(2S,3R,4S)-2,3,4-Tri(benzyloxy)-5-{[tert-butyl(dimethyl)silyl]-
oxy}pentanal (8a). Aldehyde 8a was obtained in 96% yield
(2.30 g, 4.30 mmol) by the reaction of 7a (2.4 g, 4.5 mmol), OsO4
(0.11 M in H2O, 4.0 mL, 0.44 mmol) and NMO (1.4 g, 12 mmol) in
a mixture of acetone (65 mL), H2O (15 mL) and tert-butyl alcohol
(2 mL) for 6 h at room temperature, followed by treatment of the
reaction mixture with NaIO4 (10 g) for 1 h at the same temperature.
Colorless oil. [a]2D5 (c 1.03, CHCl3) −11.1; IR (neat) m 3031, 2952,
2857, 1731, 1455, 1255, 1092, 1028, 838, 735, 697 cm−1; 1H NMR
(400 MHz, CDCl3) d 0.00 (6H, s), 0.89 (9H, s), 3.55–3.61 (1H, m),
3.67–3.77 (2H, m), 3.92 (1H, dd, J = 5.4, 1.6 Hz), 3.98–4.03 (1H,
m), 4.47–4.55 (3H, m), 4.59 (1H, d, J = 11.8 Hz), 4.67 (1H, d, J =
11.8 Hz), 4.79 (1H, d, J = 12.0 Hz), 7.23–7.38 (15H, m), 9.73 (1H,
d, J = 1.6 Hz); 13C NMR (100 MHz, CDCl3) d −5.5, −5.5, 18.1,
25.8, 61.6, 72.9, 73.1, 74.1, 78.2, 78.7, 81.2, 127.7, 128.0, 128.2,
128.4, 128.4, 137.3, 137.7, 138.0, 200.7; MS (ESI-TOF) m/z 557
[M + Na]+; HRMS calcd for C32H42NaO5Si [M + Na]+, 557.2699;
found, 557.2687.
(4R,5S,6R,7R)-4,5,6-Trihydroxy-7-methoxy-4,5,6,7-tetrahydro-
[1,2,3]triazolo[1,5-a]pyridine (6a-a). To a suspension of 20%
Pd(OH)2 on carbon (50 mg) in MeOH (1.0 mL), a solution of
5a-a (33.1 mg, 70 lmol) in MeOH (2.0 mL) was added. After
being stirred at room temperature for 11 h under a H2 atmosphere
(1 atm.), the reaction mixture was filtered. The filtrate was
concentrated under reduced pressure, and purified by column
chromatography on silica gel (CHCl3–MeOH = 10 : 1) to give
6a-a (13.8 mg, 68.8 lmol) in 96% yield. Colorless oil. [a]2D5 (c
1.00, CH3OH) +71.5; IR (neat) m 3031, 2908, 1496, 1454, 1072,
1
735 cm−1; H NMR (400 MHz, D2O) d 3.65 (3H, s), 4.07–4.12
(1H, m), 4.14 (1H, dd, J = 10.6, 7.1 Hz), 4.82 (1H, d, J = 7.1 Hz),
5.90 (1H, d, J = 3.2 Hz), 7.90 (1H, s); 13C NMR (100 MHz, D2O)
d 60.5, 68.4, 71.1, 73.5, 88.6, 134.2, 138.3; MS (ESI-TOF) m/z
202 [M + H]+; HRMS calcd for C7H12N3O4 [M + H]+, 202.0828;
found, 202.0821.
tert-Butyl(dimethyl){[(2S,3R,4S)-2,3,4-tri(benzyloxy)-5,5-dime-
thoxypentyl]oxy}silane. This compound was obtained in 100%
yield (3.90 g, 3.89 mmol) by the reaction of 8a (2.1 g, 3.9 mmol)
and HC(OMe)3 (10 mL) in the presence of pTsOH·H2O (100 mg)
for 45 min at room temperature. Colorless oil. [a]2D5 (c 1.00,
CHCl3) +7.20; IR (neat) m 3031, 2929, 2856, 1454, 1254, 1090,
(4R,5S,6R,7S)-4,5,6-Trihydroxy-7-methoxy-4,5,6,7-tetrahydro-
[1,2,3]triazolo[1,5-a]pyridine (6a-b). This compound was
prepared according to the synthesis of 6a-a and obtained in 95%
yield (12.2 mg, 60.6 lmol) by the reaction of 5a-b (30.1 mg,
64 lmol), Pd(OH)2 on carbon (20 w/w%, 50 mg) and H2 (1 atm.)
in MeOH (2.5 mL). Colorless oil. [a]2D5 (c 0.50, CH3OH) −26.6;
1
1028, 836, 733, 697 cm−1; H NMR (400 MHz, CDCl3) d 0.00
1
IR (neat) m 3031, 2908, 1496, 1454, 1072, 735 cm−1; H NMR
(6H, s), 0.88 (9H, s), 3.26 (3H, s), 3.43 (3H, s), 3.58 (1H, dd, J =
10.9, 5,5 Hz), 3.68–3.74 (2H, m), 3.75–3.81 (1H, m), 3.83–3.88
(1H, m), 4.45 (1H, d, J = 6.2 Hz), 4.63 (1H, d, J = 11.7 Hz),
4.65 (1H, d, J = 11.4 Hz), 4.66 (1H, d, J = 11.7 Hz), 4.73 (2H,
d, J = 11.7 Hz), 4.87 (1H, d, J = 11.5 Hz), 7.21–7.39 (15H, m);
13C NMR (100 MHz, CDCl3) d −5.4, 18.2, 25.9, 54.2, 55.9, 63.4,
72.9, 74.0, 74.6, 78.2, 78.3, 80.4, 105.5, 127.3, 127.4, 127.4, 127.9,
128.1, 128.1, 128.3, 138.7, 138.8, 138.9; MS (ESI-TOF) m/z 603
[M + Na]+; HRMS calcd for C34H48NaO6Si [M + Na]+, 603.3118;
found, 603.3132.
(400 MHz, D2O) d 3.83 (3H, s), 3.85 (1H, dd, J = 9.5, 8.4 Hz),
4.09 (1H, dd, J = 9.5, 6.8 Hz), 4.89 (1H, d, J = 6.8 Hz), 5.67
(1H, d, J = 6.8 Hz), 7.87 (1H, s); 13C NMR (100 MHz, D2O) d
60.9, 67.9, 73.6, 75.6, 92.5, 133.2, 139.0; ESI-MS (m/z) 202 [M +
H]+; HRMS calcd for C7H12N3O4 [M + H]+, 202.0828; found,
202.0821.
Preparation of triazolo-idose mimic (ent-5a)
tert-Butyl(dimethyl){[(2S,3S,4R)-2,3,4-tri(benzyloxy)hex-5-enyl]-
oxy}silane (7a). To
a
solution of (2S,3S,4R)-2,3,4-tris-
(2S,3R,4S)-2,3,4-Tri(benzyloxy)-5,5-dimethoxypentan-1-ol (9a).
(benzyloxy)hex-5-en-1-ol (2.1 g, 5.0 mmol),20 which was prepared
by NaBH4 reduction of 1a, and imidazole (510 mg, 7.5 mmol) in
DMF (5 mL), tert-butylchlorodimethylsilane (905 mg, 6.0 mmol)
To
a
solution of tert-butyl(dimethyl){[(2S,3R,4S)-2,3,4-tris-
(benzyloxy)-5,5-dimethoxypentyl]oxy}silane (3.9 g, 3.9 mmol) in
THF (5.0 mL), tetrabutylammonium fluoride (TBAF, 1.0 M in
2684 | Org. Biomol. Chem., 2008, 6, 2679–2685
This journal is
The Royal Society of Chemistry 2008
©